Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Filings indexed 873 across all filing types
Latest filing 2022-08-09 Major Shareholding Noti…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding ('Reason for major shareholding notification Sell') by a holder ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension') in an issuer ('Episurf Medical AB'). It explicitly lists the 'Before the transaction' and 'After the transaction' share quantities and resulting percentages, culminating in a 'Group total holdings' section showing a total voting rights percentage of 4.94644%. This structure is characteristic of a Major Shareholding Notification, where an entity reports crossing a threshold (in this case, falling below 5%). This aligns directly with the definition for Major Shareholding Notification (MRQ). The document is short and appears to be the official filing itself, not an announcement of a report.
2022-08-09 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage for a specific holder ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension'). It explicitly lists the 'Reason for major shareholding notification Sell' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage of voting rights (4.9945%). This structure is characteristic of a notification regarding a change in significant ownership thresholds. Based on the provided definitions, this aligns perfectly with 'Major Shareholding Notification' (Code: MRQ). The document is short and appears to be the notification itself, not an announcement of a larger report.
2022-08-08 English
New patent approval in Hong Kong for Episurf Medical
Regulatory Filings Classification · 1% confidence The document announces the granting of a new patent in Hong Kong for Episurf Medical concerning surgical instruments related to their Episealer® Talus technology. This is a specific announcement regarding intellectual property rights and technological development, not a standard financial filing like a 10-K, ER, or IR. Among the provided categories, 'Intellectual Property' is not explicitly listed, but the content strongly relates to the company's core assets and developments. Since the document is a specific announcement about a patent approval, and there is no direct category for 'Patent Approval', I must evaluate the closest fit. The document is a specific, non-financial regulatory/corporate update. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for specific, non-standard corporate announcements that don't fit the defined financial or governance categories, although 'IP' (Intellectual Property) might be a better internal category if available. Since 'IP' is not an option, and this is a formal announcement of a legal/regulatory event (patent grant), RNS serves as the best general regulatory announcement category.
2022-07-20 English
Nytt patentbeviljande i Hongkong för Episurf Medical
Regulatory Filings Classification · 1% confidence The document is a short announcement (1840 characters) detailing that Episurf Medical has been granted a new patent in Hong Kong for surgical tools related to their Episealer® Talus technology. The text concludes with a statement that this information is what the company is obligated to disclose under the EU Market Abuse Regulation (MAR) and specifies the time of release. This is not a comprehensive financial report (like 10-K or IR), nor is it a standard earnings release (ER) or management discussion (MDA). It is a specific, material corporate event announcement that doesn't fit the defined categories like DIRS, DIV, or CAP. Since it is a specific regulatory disclosure concerning intellectual property/corporate news that doesn't fit the other specific categories, it falls best under the general 'Regulatory Filings' fallback category (RNS), which covers miscellaneous regulatory announcements.
2022-07-20 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport 1 januari – 30 juni 2022' (Interim Report January 1 – June 30, 2022). It contains comprehensive financial data, including income statements, balance sheet information, management commentary, and operational updates for the first half of the fiscal year. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. H1 2022
2022-07-15 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report 1 January – 30 June 2022' and contains comprehensive financial statements, including net sales, operating profit/loss, cash flow, and balance sheet data for the specified period. It also includes management commentary, business updates, and forward-looking statements. It is clearly a periodic financial report for a duration shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2022
2022-07-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.